Back to News & Insights
ACH News & Events

News

ObesityWeekObesity & Metabolic HealthMedia & Conference Participation

November 13, 2026

Gaylord National Resort and Convention Center, National Harbor, Maryland

ObesityWeek 2026: ACH Follows the Week Story by Story

The American Chamber of Health is an accredited media partner for ObesityWeek 2026. This entry tells the week through the official session cards The Obesity Society has shared, one story for each card, with the session, the day and the time exactly as the card prints them.

A media partner, following the week as it unfolds

ObesityWeek 2026, the 44th Annual Scientific Meeting of The Obesity Society, runs from Saturday November 14 to Tuesday November 17 at the Gaylord National Resort and Convention Center in National Harbor, Maryland. ACH News and Insights takes part as an accredited media partner, and our coverage follows the official ObesityWeek feed. This entry is built only from the session cards in that feed. Every story below sits beside the card it comes from, shown whole.

The constant chatter patients call food noise

Session: Do You Hear What I Hear? Perspectives on Food Noise
When: Saturday November 14, 2026, 1:30 to 2:30 PM Eastern
Theme named on the card: Understanding Appetite and the Brain

Four speakers, four perspectives on food noise, the constant mental chatter about food that patients describe.

Official ObesityWeek session card

Shaped before the first breath

Session: Marked Before We Draw Breath: How Parental Obesity Shapes the Brain and Body
When: Monday November 16, 2026, 8:30 to 9:30 AM Eastern
Theme named on the card: Understanding Appetite and the Brain

This symposium examines how parental obesity shapes the brain and body of the next generation.

Official ObesityWeek session card

Success measured in more than pounds

Session: TOS/ACSM Joint Symposium: Moving Beyond Weight: Physiological and Psychological Engagement for Physical Activity in Obesity Treatment
When: Monday November 16, 2026, 8:30 to 9:30 AM Eastern
Theme named on the card: Beyond Weight Loss

A joint symposium with the American College of Sports Medicine on physical activity in obesity treatment, engaging patients in body and in mind. Six speakers share the session.

Official ObesityWeek session card

The conversation between gut and brain

Session: Though the Brain Be Noble, the Gut Is Not Silent: Neural Plasticity of the Gut Brain Axis
When: Monday November 16, 2026, 10:00 to 11:30 AM Eastern
Theme named on the card: Understanding Appetite and the Brain

This symposium follows the neural plasticity of the gut brain axis, the signalling system between gut and brain that shapes appetite.

Official ObesityWeek session card

Answering the myths patients bring through the door

Session: Navigating the Noise: Supplements, Social Media Myths, and GLP 1 Realities
When: Monday November 16, 2026, 10:00 to 11:30 AM Eastern
Theme named on the card: Real World Challenges in Obesity Care

Supplements, social media myths and GLP 1 realities, set side by side in one symposium.

Official ObesityWeek session card

Why eating behaves the way it does

Session: TOS/SSIB Collaborative Symposium: Much Ado About Eating: The Neurobiology of Eating Behavior
When: Monday November 16, 2026, 1:30 to 2:30 PM Eastern
Theme named on the card: Understanding Appetite and the Brain

A collaborative symposium with the Society for the Study of Ingestive Behavior, on the neurobiology of eating behavior.

Official ObesityWeek session card

Staging and practice for older adults

Session: TOS/EASO/GSA Symposium: Bridging Science and Practice for Older Adults: Integrating the 2026 EASO Staging Framework and GSA KAER Toolkit
When: Monday November 16, 2026, 1:30 to 2:30 PM Eastern
Theme named on the card: Beyond Weight Loss

This symposium bridges science and practice for older adults, integrating the 2026 EASO staging framework and the GSA KAER toolkit.

Official ObesityWeek session card

Protecting muscle while the weight comes off

Session: Muscle in the Cross Hairs: IMAT, GLP 1s, and the Battle for Lean Mass
When: Monday November 16, 2026, 5:00 to 6:30 PM Eastern
Theme named on the card: Beyond Weight Loss

An evening symposium on IMAT, GLP 1s and the battle for lean mass during weight loss.

Official ObesityWeek session card

When one treatment is not enough

Session: Merging Modalities: A Unified Approach to Treating the Patient with BMI >35
When: Tuesday November 17, 2026, 10:00 to 11:00 AM Eastern
Theme named on the card: Next Generation Obesity Therapies

A unified approach to treating the patient with BMI over 35, merging modalities into one plan.

Official ObesityWeek session card

The institutions behind the week

The cards above sit inside a much larger week. These are the institutions whose people, science and medicines fill the program.

Pennington Biomedical Research Center: The Baton Rouge nutrition research institute sends 19 speakers, more than any single institution at ObesityWeek 2026.

Mayo Clinic: The Rochester and Florida campuses send 18 speakers, the largest delegation from any health system at the meeting.

Yale University: Home of Dr. Ania Jastreboff, who receives the Presidential Medal at the Presidential Plenary and presents results across the week.

UT Southwestern Medical Center: The Dallas academic center sends about 15 speakers, among the largest university delegations here.

Novo Nordisk: The Danish company behind Ozempic and Wegovy holds one of the two largest footprints at the show, with around 57 of its people in the attendee directory.

Eli Lilly: Maker of Mounjaro and Zepbound, holding more suites than any other company here, with nine speakers on the program.

Pfizer: One of the largest drug companies in the world sends 28 people, the largest company team in the attendee directory after Novo Nordisk.

The clinical research firms: ICON, Parexel, Medpace and Syneos Health all exhibit, the trial business that stands behind the medicines on show.

The societies: The Obesity Society hosts the week, and the Gerontological Society of America, the American Diabetes Association and the American Academy of Pediatrics all exhibit alongside it.

ACH press release: the real world picture on GLP 1 medicines

Session: Treatment Access, Coverage, and Real World Outcomes
When: Saturday November 14, 2026, 12:30 to 1:30 PM Central

ACH press release banner showing Alison Sexton Ward, MS, PhD, ObesityWeek 2026

Cost, Not Side Effects, Is the Main Reason Americans Stop GLP 1 Medicines, USC Researcher Tells ObesityWeek 2026

WASHINGTON, DC, November 14, 2026 — Insurance claims are missing a large share of real world GLP 1 use in the United States, because many people pay cash and never appear in claims data. That was the central finding Alison Sexton Ward of the University of Southern California presented at ObesityWeek 2026, in the session Treatment Access, Coverage, and Real World Outcomes. Her evidence came from the Understanding America Study, the national survey program run by the University of Southern California.

The survey, fielded from October to December 2025, covered 9,139 respondents, including 1,256 current or former GLP 1 users. It found that 13.7 percent of respondents have used a GLP 1, and that 48.6 percent of users take it mainly for weight loss.

The coverage gap sits at the center of the findings. For diabetes, 97 percent of users have insurance coverage for their GLP 1. For weight loss, over 40 percent have no insurance coverage at all, and a further large share face a copay. Ward showed that clinical need drives interest in a GLP 1, but income and insurance coverage drive who actually receives one. Weight loss users also obtain prescriptions and fills outside traditional medical routes at higher rates, including compounding pharmacies and online pharmacies.

On results, users taking a GLP 1 mainly for weight loss reached about 19 percent weight loss over two years, against about 14 percent over two years for people treating diabetes.

On stopping, the survey found about 12 percent of users had stopped by six months, 22 percent by one year, and 33 percent by two years. The strongest driver of stopping was out of pocket cost. A copay of $51 or more predicted discontinuation more strongly than any side effect, and the only side effect that reached significance in her models was vomiting. Having diabetes as the primary reason for treatment made people more likely to stay on therapy.

"We need to look to other data sources to get the full picture for the weight loss treatment," Ward told the session. Her conclusion was direct: expanding access requires policies that increase insurance coverage and reduce out of pocket costs.

For healthcare leaders, the message is practical. Figures drawn only from insurance claims will understate real world use and misread why patients stop. Coverage design, and the copay level in particular, is the lever that decides whether patients stay on a medicine that is working for them.

The American Chamber of Health is covering ObesityWeek 2026, hosted by The Obesity Society, as part of its News and Insights reporting for healthcare leaders, clinicians, and organizations across the United States.

Media credit: ObesityWeek 2026 is the annual scientific meeting of The Obesity Society, held November 14 to 17, 2026, in Washington, DC. The American Chamber of Health attends ObesityWeek 2026 as a media partner and publishes this coverage for its members and readers, with thanks to The Obesity Society and the ObesityWeek organizers.

About the American Chamber of Health

The American Chamber of Health brings together professionals, institutions, innovators, investors, and public partners to build initiatives that improve lives. ACH exists to be the connective infrastructure of healthcare, bringing together the people and institutions who normally work in silos, so healthcare works better for everyone. We turn relationships into solutions. Contact: info@americanchamberofhealth.org

Follow the week with us

Follow each day of ObesityWeek 2026 on ACH News and Insights. Our coverage runs through Tuesday November 17.

All session cards and pictures in this entry come from The Obesity Society and the official ObesityWeek feed.

Stay informed

Get Insights in your inbox